Laurence Collette

Active 1996–2023

128
Papers
45,773
Citations
97
h-index
127
i10-index

Citations

Citations per year for Laurence Collette1931: 1 citations1993: 1 citations1997: 12 citations1998: 34 citations1999: 34 citations2000: 53 citations2001: 92 citations2002: 108 citations2003: 125 citations2004: 130 citations2005: 156 citations2006: 182 citations2007: 205 citations2008: 262 citations2009: 263 citations2010: 302 citations2011: 283 citations2012: 278 citations2013: 289 citations2014: 293 citations2015: 293 citations2016: 285 citations2017: 283 citations2018: 277 citations2019: 973 citations2020: 1,132 citations2021: 889 citations2022: 719 citations2023: 445 citations2024: 806 citations2025: 290 citations2026: 10 citations1932–1992: no citations, so these years are not shown1994–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,373 citing papers, 21.3% of this breakdownUnited Kingdom: 1,169 citing papers, 7.4% of this breakdownGermany: 1,000 citing papers, 6.3% of this breakdownItaly: 983 citing papers, 6.2% of this breakdownFrance: 906 citing papers, 5.7% of this breakdownNetherlands: 895 citing papers, 5.6% of this breakdownCanada: 793 citing papers, 5% of this breakdownChina: 760 citing papers, 4.8% of this breakdownBelgium: 590 citing papers, 3.7% of this breakdownSwitzerland: 524 citing papers, 3.3% of this breakdownSpain: 519 citing papers, 3.3% of this breakdownJapan: 437 citing papers, 2.8% of this breakdown
0%21.3%Other 24.6%

Fields

  • Medicine83.2%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Physics and Astronomy1%
  • Nursing0.9%
  • Engineering0.6%
  • Immunology and Microbiology0.6%
  • Other2.6%

Topics

  • Prostate Cancer Treatment and Research5.3%
  • Prostate Cancer Diagnosis and Treatment4.9%
  • Colorectal Cancer Surgical Treatments4%
  • Brain Metastases and Treatment3.5%
  • Bladder and Urothelial Cancer Treatments3.2%
  • Advanced Radiotherapy Techniques2.9%
  • Other76.2%

Coauthors

All papers

Open in search
  1. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 1,066

  2. Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 2,002

  3. Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

    Authors: , , , , , , , , , - New England Journal of Medicine 2006 cited by 2,713

  4. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

    Authors: , , , , , , , , , , , , , , , - European Urology 2015 cited by 640

  5. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley Wilder Smith, Katherine M Soltys, Martin Taphoorn, Galina Velikova, Andrew Bottomley - The Lancet Oncology 2020 cited by 306

  6. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 434

  7. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  8. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 cited by 490

  9. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

    Authors: , , , , , , , , , , - The Lancet 2005 cited by 1,024

  10. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2008 cited by 1,945

  11. Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

    Authors: , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,128

  12. Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials

    Authors: , , , , , , , , , , , , , , , , , , , - European Urology 2021 cited by 133

  13. Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Vaughn, Cora N. Sternberg, Axel Heidenreich, J. Beyer - Journal of Clinical Oncology 2021 cited by 238

  14. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Blanchard, Jean Bourhis, Benjamin Lacas, Jean‐Pierre Pignon, Jacques Bernier, Quynh‐Thu Le, Jens Overgaard, Masheh KB Parmar, Andy Trotti, Jai Prakash Agarwal, Anne Aupérin, Kian Ang, Hassan K. Awwad, Almalina Bacigalupo, Harry Bartelink, E Benhamou, Jacques Bernier, Pierre Blanchard, Jean Bourhis, Wilfried Budach, Imjai Chitapanarux, Kwan Ho Cho, Laurence Collette, Renzo Corvò, Carla Dani, Stanley Dische, W. Dobrowsky, James W. Denham, C.M.L. Driessen, C. Fallai, Beth M. Beadle, Sarbani Ghosh Laskar, Sushmita Ghoshal, Cai Grau, Vincent Grégoire, John Hay, Carla van Herpen, A Hliniak, Jørgen Johansen, Claus Andrup Kristiansen, Valentina Krstevska, Benjamin Lacas, Johannes A. Langendijk, M. Lapeyre, Quynh‐Thu Le, Mohamed Lotayef, B. Maciejewski, P. Maingon, Wojciech Michalski, Sung Ho Moon, Per Nilsson, Patrizia Olmi, Matthew Nankivell, Kinji Nishiyama, Brian O’Sullivan, Jens Overgaard, Mahesh Parmar, Jean‐Pierre Pignon, Michael Poulsen, Kunnambath Ramadas, Anupam Rishi, David I. Rosenthal, Giuseppe Sanguineti, Michele I. Saunders, Christian Sire, Krzysztof Składowski, Luís Souhami, Rafał Suwiński, Z. Szutkowski, Nitin Tandon and 12 more - The Lancet Oncology 2017 cited by 339

  15. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data

    Authors: , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 576

  16. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 728

  17. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 682

  18. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

    Authors: , , , , , , , , , , , , - European Journal of Cancer 2005 cited by 545

  19. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 284

  20. Duration of Androgen Suppression in the Treatment of Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 966

  21. Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 628

  22. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 1,021

  23. Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

    Authors: , , , , , , , , - European Urology 2002 cited by 683

  24. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 387